Circulating tumor cells: Detection, characterization and clinical impact;Cellules tumorales circulantes: Détection, caractérisation et intérêts cliniques

Revue Medicale de Liege

Volumn 66, Issue 5-6, 2011, Pages 279-284

  Gilles, Ch ^a   Collignon, J ^a   Noel A ^a   Jerusalem, G ^a   Foidart, J M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Breast cancer; Circulating tumor cells (CTCs); Disseminated tumor cells (DTCs)

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER RESEARCH; CANCER SURVIVAL; CIRCULATING TUMOR CELL; CLINICAL EFFECTIVENESS; DISSEMINATED TUMOR CELL; HUMAN; METASTASIS; PREDICTIVE VALUE; PROGNOSIS; REVIEW; TUMOR CELL;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING;

EID: 80051705360     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Paterlini-Brechot P, Benali NL. - Circulating tumor cells (CTC) detection : clinical impact and future directions. Cancer Lett, 2007, 253, 180-204. (Pubitemid 47017533)
2. Pantel K, Alix-Panabieres C. - Circulating tumour cells in cancer patients : challenges and perspectives. Trends Mol Med, 2010, 16, 398-406
3. Yu M, Stott S, Toner M, et al. - Circulating tumor cells : approaches to isolation and characterization. J Cell Biol, 2011, 192, 373-382.
4. Pachmann K. - Longtime recirculating tumor cells in breast cancer patients. Clin Cancer Res, 2005, 11, 5657-5658. (Pubitemid 41060846)
5. Ross JS, Slodkowska EA. - Circulating and disseminated tumor cells in the management of breast cancer. Am J Clin Pathol, 2009, 132, 237-245.
6. Cristofanilli M, Budd GT, Ellis MJ, et al. - Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med, 2004, 351, 781-791. (Pubitemid 39095313)
7. Hayes DF, Cristofanilli M, Budd GT, et al. - Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res, 2006, 12, 4218-4224.
8. de Bono JS, Scher HI, Montgomery RB, et al. - Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res, 2008, 14, 6302-6309.
9. Cohen SJ, Punt CJ, Iannotti N, et al. - Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol, 2008, 26, 3213-3221.
10. Riethdorf S, Fritsche H, Muller V, et al. - Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer : a validation study of the CellSearch system. Clin Cancer Res, 2007, 13, 920- 928.
11. Miller, M. C., Doyle, G. V., and Terstappen, L. W. - Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncol, 2010, ID: 617421.
12. Cristofanilli M, Reuben J, Uhr J. - Circulating tumor cells in breast cancer : fiction or reality? J Clin Oncol, 2008, 26, 3656-3657.
13. Botteri E, Sandri MT, Bagnardi V, et al. - Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Res Treat, 2010, 122, 211-217.
14. Danila DC, Heller G, Gignac GA, et al. - Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res, 2007, 13, 7053-7058. (Pubitemid 350276887)
15. Bidard FC, Mathiot C, Delaloge S, et al. - Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol, 2010, 21, 729- 733.
16. Muller V, Stahmann N, Riethdorf S, et al. - Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res, 2005, 11, 3678-3685. (Pubitemid 40685584)
17. Pachmann K, Camara O, Kavallaris A, et al. - Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer : a new tool for therapy monitoring. Breast Cancer Res, 2005, 7, R975- R979.
18. Pierga JY, Bidard FC, Mathiot C, et al. - Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res, 2008, 14, 7004-7010.
19. Riethdorf S, Muller V, Zhang L, et al. - Detection and HER2 expression of circulating tumor cells : prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin Cancer Res, 2010, 16, 2634-2645.
20. Muller SL, Portwich M, Schmidt A, et al. - The tight junction protein occludin and the adherens junction protein alpha-catenin share a common interaction mechanism with ZO-1. J Biol Chem, 2005, 280, 3747-3756. (Pubitemid 40223843)
21. Meng S, Tripathy D, Shete S, et al. - HER2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci U S A, 2004, 101, 9393-9398. (Pubitemid 38812885)
22. Wulfing P, Borchard J, Buerger H, et al. - HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clin Cancer Res, 2006, 12, 1715-1720.
23. Muller V, Pantel K. - HER2 as marker for the detection of circulating tumor cells. Breast Cancer Res Treat, 2009, 117, 535-537.
24. Fehm T, Muller V, Aktas B, et al. - HER2 status of circulating tumor cells in patients with metastatic breast cancer : a prospective, multicenter trial. Breast Cancer Res Treat, 2010, 124, 403-412.
25. Hayes DF, Walker TM, Singh B, et al. - Monitoring expression of HER2 on circulating epithelial cells in patients with advanced breast cancer. Int J Oncol, 2002, 21, 1111-1117.
26. Aktas B, Tewes M, Fehm T, et al. - Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res, 2009, 11, R46.
27. Raimondi C, Gradilone A, Naso G, et al. - Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res Treat, 2011, Feb 5 (Epub ahead of print).
28. Yang J, Weinberg RA. - Epithelial-mesenchymal transition : at the crossroads of development and tumor metastasis. Dev Cell, 2008, 14, 818-829. (Pubitemid 351757205)
29. Kalluri R, Weinberg RA. - The basics of epithelial-mesenchymal transition. J Clin Invest, 2009, 119, 1420- 1428.
30. Bonnomet A, Brysse A, Tachsidis A, et al. - Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia, 2010, 15, 261-273.
31. Klein CA. - Parallel progression of primary tumours and metastases. Nat Rev Cancer, 2009, 9, 302-312.
32. Riethdorf S, Pantel K. - Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients : current state of detection and characterization. Pathobiology, 2008, 75, 140-148. (Pubitemid 351820732)
33. Alix-Panabieres C, Riethdorf S, Pantel K. - Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res, 2008, 14, 5013-5021.
34. Braun S, Auer D, Marth C. - The prognostic impact of bone marrow micrometastases in women with breast cancer. Cancer Invest, 2009, 27, 598-603.
35. Braun S, Vogl FD, Naume B, et al. - A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med, 2005, 353, 793-802. (Pubitemid 41215488)
36. Bidard FC, Vincent-Salomon A, Gomme S, et al. - Disseminated tumor cells of breast cancer patients : a strong prognostic factor for distant and local relapse. Clin Cancer Res, 2008, 14, 3306-3311.
37. Balic M, Dandachi N, Lin, H, and Datar RH. - Cancer metastasis : advances in the detection and characterization of disseminated tumour cells facilitate clinical translation. Natl Med J India, 2005, 18, 250-255. (Pubitemid 43103630)
38. Muller V, Alix-Panabieres C, Pantel K. - Insights into minimal residual disease in cancer patients : implications for anti-cancer therapies. Eur J Cancer, 2010, 46, 1189-1197.
39. Noe¨l A, Gilles Ch, Foidart J-M. - Invasion et dissémination métastatiques dans le cancer du sein : mécanismes. Rev Med Liège, 2011, 66, 274-278.